UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: August 14, 2014
Commission File Number 333-133347
PEPTIDE TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
Nevada 98-0479983
---------------------------------- ------------------------
State or other jurisdiction of (I.R.S. Employer
incorporation or organization Identification No.)
601 Union Street, Two Union Square, 42nd Floor, Seattle, Washington 98101
-------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (206) 236-9555
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: [ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS
Item 1.01 Entry into a Material Definitive Agreement.
On August 14, 2014, Peptide Technologies, Inc. ("the Company") entered into an
Asset Purchase Agreement with All-Sea Coatings Ltd.
All-Sea Coatings Ltd has acquired from Peptide Technologies Inc. the
non-commercialized re- formulated assets, that were developed by the Company in
consideration of $10,000. (Ten Thousand Dollars) and a 3% Royalty of all Gross
Sales & Revenue, to be paid to Peptide Technologies Inc. derived from All-Sea
Coatings Ltd, until such a time should occur that Formulas and or All-Sea
Coatings Ltd (The Company) is sld.
All-Sea Coatings Ltd shall cover all costs, expenses and capital, including all
monies for additional research and development etc., required to commercialize
all of the coatings.
All-Sea Coatings Ltd shall pay 10% of the gross sale to Peptide Technologies
Inc. derived from any formula sold, out right, and or, if All-Sea Coatings (the
Company) is purchased, 10% of the gross sale of All-Sea Coatings Ltd will be
paid to Peptide Technologies Inc.
- 2 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.
PEPTIDE TECHNOLOGIES, INC.
By: /s/ Baxter Koehn
----------------------------------
Baxter Koehn
CFO
Date: August 26, 2014
- 3 -